We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Inhibiting miRNA as a Foundation for New Gene Therapies?

News   Jul 29, 2019 | Original story from the Toyko Medical and Dental University

 
Inhibiting miRNA as a Foundation for New Gene Therapies?

This image illustrates the molecular mechanism how double-stranded HDO-antimiR silences the targeted microRNA within cells in comparison with the original single-stranded antimiR. These findings provide new insights into the biology of miRNA silencing and support the potential of this new class of molecules for use in treating miRNA-related diseases, such as cancer and cardiovascular disease. "HDO-antimiR appears to have different mechanisms of action compared with the parent antimiR," states first-author Yoshioka. "Thus, given its heightened intracellular miRNA-silencing potency, HDO-antimiR and the techniques that we used to construct it represent a new direction for miRNA regulation research." Credit: Department of Neurology and Neurological Science, TMDU.

 
 
Advertisement
 

RELATED ARTICLES

The National Gene Vector Biorepository

News

Gene therapy investigators can greatly benefit from the resources and services provided by the National Gene Vector Biorepository.

READ MORE

Aiding COVID-19 Data Analysis

News

Researchers from the Centre for Genomic Regulation (CRG) have launched a new database to advance the international research efforts studying COVID-19.

READ MORE

Novel Antibiotic Resistance Gene Has Spread Unnoticed

News

A completely new resistance gene, which is likely to counteract the newest aminoglycoside-drug plazomycin, was recently discovered by scientists at the University of Gothenburg.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE